Second-line treatment of patients with metastatic colorectal cancer

被引：14
|
作者：
Rougier, P [1 ]
Lepere, C [1 ]
机构：
[1] Hop Ambroise Pare, F-92100 Boulogne, France
来源：
SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 06期
关键词：
D O I：
10.1053/j.semonocol.2005.06.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S48 / S54
页数：7
相关论文
共 50 条
  • [1] Options for Second-Line Treatment in Metastatic Colorectal Cancer
    Lee, James J.
    Sun, Weijing
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 46 - 54
  • [2] Evaluation of safety of bevacizumab as second-line treatment of patients with metastatic colorectal cancer
    Todorovic, Vladimir
    Saric, Nada Cicmil
    Lakicevic, Jadranka
    Sorat, Milan
    [J]. JOURNAL OF BUON, 2017, 22 (05): : 1131 - 1136
  • [3] Second-line therapy for metastatic colorectal cancer
    Price, Timothy J.
    [J]. LANCET ONCOLOGY, 2015, 16 (05): : 476 - 477
  • [4] Second-line management of metastatic colorectal cancer
    Gallagher, David J.
    Kemeny, Nancy
    [J]. CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 25 - 32
  • [5] XELIRI compared with FOLFIRI as a second-line treatment in patients with. metastatic colorectal cancer
    Cui, Chengxu
    Shu, Chang
    Yang, Yi
    Liu, Junbao
    Shi, Shuping
    Shao, Zhujun
    Wang, Nan
    Yang, Ting
    Hu, Songnian
    [J]. ONCOLOGY LETTERS, 2014, 8 (04) : 1864 - 1872
  • [6] Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer
    Vyzula, R
    Kocáková, I
    Demlová, R
    Kiss, I
    Dusek, L
    Jarkovsky, J
    [J]. NEOPLASMA, 2006, 53 (02) : 119 - 127
  • [7] Metastatic colorectal cancer:: First- and second-line treatment in 2005
    Rougier, P
    Lepère, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S15 - S20
  • [8] Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA
    Lisa M. Hess
    Zhanglin Lin Cui
    Daniel S. Mytelka
    Yimei Han
    Robert Goodloe
    William Schelman
    [J]. International Journal of Colorectal Disease, 2019, 34 : 581 - 588
  • [9] Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA
    Hess, Lisa M.
    Cui, Zhanglin Lin
    Mytelka, Daniel S.
    Han, Yimei
    Goodloe, Robert
    Schelman, William
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (04) : 581 - 588
  • [10] IROX as second-line therapy for metastatic colorectal cancer
    Alberto Sobrero
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 248 - 250
12345